Christopher Phelps

Christopher Phelps

Company: Nurix Therapeutics

Job title: Vice President & Head of Early Drug Discovery Drug Discovery Technologies


Seminar: Utilizing DEL as a Primary Discovery Engine for Targeted Protein Degradation

For more information on this session, please download the full event guide.

Day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.